vs
Axsome Therapeutics, Inc.（AXSM）与IDEAYA Biosciences, Inc.（IDYA）财务数据对比。点击上方公司名可切换其他公司
IDEAYA Biosciences, Inc.的季度营收约是Axsome Therapeutics, Inc.的1.1倍（$207.8M vs $196.0M），IDEAYA Biosciences, Inc.净利率更高（57.4% vs -14.6%，领先71.9%），IDEAYA Biosciences, Inc.自由现金流更多（$142.2M vs $-18.7M）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
IDEAYA Biosciences是一家临床阶段生物技术企业，专注于肿瘤学领域，研发针对基因定义癌症的靶向疗法及合成致死治疗方案，推进多肿瘤类型的候选药物管线开发，与行业伙伴合作提升全球创新癌症治疗方案的可及性。
AXSM vs IDYA — 直观对比
营收规模更大
IDYA
是对方的1.1倍
$196.0M
净利率更高
IDYA
高出71.9%
-14.6%
自由现金流更多
IDYA
多$160.9M
$-18.7M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $196.0M | $207.8M |
| 净利润 | $-28.6M | $119.2M |
| 毛利率 | — | — |
| 营业利润率 | -13.8% | 52.2% |
| 净利率 | -14.6% | 57.4% |
| 营收同比 | 65.0% | — |
| 净利润同比 | 61.9% | 330.1% |
| 每股收益（稀释后） | $-0.55 | $1.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMIDYA
| Q4 25 | $196.0M | — | ||
| Q3 25 | $171.0M | $207.8M | ||
| Q2 25 | $150.0M | — | ||
| Q1 25 | $121.5M | — | ||
| Q4 24 | $118.8M | — | ||
| Q3 24 | $104.8M | $0 | ||
| Q2 24 | $87.2M | $0 | ||
| Q1 24 | $75.0M | $0 |
净利润AXSMIDYA
| Q4 25 | $-28.6M | — | ||
| Q3 25 | $-47.2M | $119.2M | ||
| Q2 25 | $-48.0M | — | ||
| Q1 25 | $-59.4M | — | ||
| Q4 24 | $-74.9M | — | ||
| Q3 24 | $-64.6M | $-51.8M | ||
| Q2 24 | $-79.3M | $-52.8M | ||
| Q1 24 | $-68.4M | $-39.6M |
营业利润率AXSMIDYA
| Q4 25 | -13.8% | — | ||
| Q3 25 | -27.0% | 52.2% | ||
| Q2 25 | -24.5% | — | ||
| Q1 25 | -46.9% | — | ||
| Q4 24 | -61.1% | — | ||
| Q3 24 | -59.8% | — | ||
| Q2 24 | -89.5% | — | ||
| Q1 24 | -89.7% | — |
净利率AXSMIDYA
| Q4 25 | -14.6% | — | ||
| Q3 25 | -27.6% | 57.4% | ||
| Q2 25 | -32.0% | — | ||
| Q1 25 | -48.9% | — | ||
| Q4 24 | -63.1% | — | ||
| Q3 24 | -61.7% | — | ||
| Q2 24 | -91.0% | — | ||
| Q1 24 | -91.1% | — |
每股收益（稀释后）AXSMIDYA
| Q4 25 | $-0.55 | — | ||
| Q3 25 | $-0.94 | $1.33 | ||
| Q2 25 | $-0.97 | — | ||
| Q1 25 | $-1.22 | — | ||
| Q4 24 | $-1.54 | — | ||
| Q3 24 | $-1.34 | $-0.60 | ||
| Q2 24 | $-1.67 | $-0.68 | ||
| Q1 24 | $-1.44 | $-0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $322.9M | $786.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $88.3M | $1.1B |
| 总资产 | $689.8M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AXSMIDYA
| Q4 25 | $322.9M | — | ||
| Q3 25 | $325.3M | $786.9M | ||
| Q2 25 | $303.0M | — | ||
| Q1 25 | $300.9M | — | ||
| Q4 24 | $315.4M | — | ||
| Q3 24 | $327.3M | $920.0M | ||
| Q2 24 | $315.7M | $701.7M | ||
| Q1 24 | $331.4M | $698.8M |
股东权益AXSMIDYA
| Q4 25 | $88.3M | — | ||
| Q3 25 | $73.7M | $1.1B | ||
| Q2 25 | $73.1M | — | ||
| Q1 25 | $53.2M | — | ||
| Q4 24 | $57.0M | — | ||
| Q3 24 | $92.9M | $1.2B | ||
| Q2 24 | $102.9M | $931.7M | ||
| Q1 24 | $144.0M | $935.3M |
总资产AXSMIDYA
| Q4 25 | $689.8M | — | ||
| Q3 25 | $669.3M | $1.2B | ||
| Q2 25 | $639.8M | — | ||
| Q1 25 | $596.7M | — | ||
| Q4 24 | $568.5M | — | ||
| Q3 24 | $561.5M | $1.2B | ||
| Q2 24 | $548.2M | $973.7M | ||
| Q1 24 | $545.7M | $961.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.7M | $142.2M |
| 自由现金流经营现金流 - 资本支出 | $-18.7M | $142.2M |
| 自由现金流率自由现金流/营收 | -9.6% | 68.4% |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | 1.19× |
| 过去12个月自由现金流最近4个季度 | $-93.9M | $13.5M |
8季度趋势，按日历期对齐
经营现金流AXSMIDYA
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $1.0M | $142.2M | ||
| Q2 25 | $-32.4M | — | ||
| Q1 25 | $-43.4M | — | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.6M | $-49.2M | ||
| Q2 24 | $-30.1M | $-32.9M | ||
| Q1 24 | $-53.5M | $-43.8M |
自由现金流AXSMIDYA
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | $142.2M | ||
| Q2 25 | $-32.4M | — | ||
| Q1 25 | $-43.7M | — | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.7M | $-49.7M | ||
| Q2 24 | $-30.2M | $-33.9M | ||
| Q1 24 | $-53.6M | $-45.1M |
自由现金流率AXSMIDYA
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | 68.4% | ||
| Q2 25 | -21.6% | — | ||
| Q1 25 | -36.0% | — | ||
| Q4 24 | -22.1% | — | ||
| Q3 24 | -17.9% | — | ||
| Q2 24 | -34.6% | — | ||
| Q1 24 | -71.4% | — |
资本支出强度AXSMIDYA
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率AXSMIDYA
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
